Published in BMC Cancer on March 20, 2012
Personalized targeted therapy for lung cancer. Int J Mol Sci (2012) 1.02
Emerging therapeutic biomarkers in endometrial cancer. Biomed Res Int (2013) 0.93
Leptomycin B reduces primary and acquired resistance of gefitinib in lung cancer cells. Toxicol Appl Pharmacol (2017) 0.75
Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A (2003) 59.17
The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell (2008) 46.08
Identification of human brain tumour initiating cells. Nature (2004) 38.87
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science (2007) 32.68
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med (1997) 32.63
Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med (2005) 31.48
EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. N Engl J Med (2005) 26.35
Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain. PLoS Med (2005) 25.93
Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell (2003) 20.16
Identification of pancreatic cancer stem cells. Cancer Res (2007) 18.36
Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med (1996) 17.51
Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell (2007) 14.87
Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature (2003) 14.35
Screening for epidermal growth factor receptor mutations in lung cancer. N Engl J Med (2009) 13.47
MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib. Proc Natl Acad Sci U S A (2007) 11.85
Cancer stem cells: an old idea--a paradigm shift. Cancer Res (2006) 9.76
Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev (1998) 8.51
Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ (2007) 8.08
Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib. Proc Natl Acad Sci U S A (2005) 6.82
Prospective phase II study of gefitinib for chemotherapy-naive patients with advanced non-small-cell lung cancer with epidermal growth factor receptor gene mutations. J Clin Oncol (2006) 6.55
CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res (2007) 6.21
The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities. Eur J Cancer (2001) 5.96
Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer. J Clin Oncol (2007) 5.55
Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition. Cancer Res (2005) 5.33
Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients. Clin Cancer Res (2005) 4.94
Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci U S A (2009) 4.19
Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Cancer Res (2010) 3.18
TGF-beta IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer. Proc Natl Acad Sci U S A (2010) 2.72
Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens. Cancer Res (2007) 2.34
Mechanisms of drug inhibition of signalling molecules. Nature (2006) 2.27
Correlation of anchorage-independent growth with tumorigenicity of chemically transformed mouse epidermal cells. Cancer Res (1978) 2.23
Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. Cancer Res (2007) 2.22
Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line. Lung Cancer (2008) 2.10
Kinase switching in mesenchymal-like non-small cell lung cancer lines contributes to EGFR inhibitor resistance through pathway redundancy. Clin Exp Metastasis (2008) 1.94
Establishment and characterization of a model of acquired resistance to epidermal growth factor receptor targeting agents in human cancer cells. Clin Cancer Res (2009) 1.85
Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers. PLoS One (2009) 1.82
The pluripotency regulator Oct4: a role in somatic stem cells? Cell Cycle (2008) 1.79
Epidermal growth factor receptor: a promising target in solid tumours. Cancer Treat Rev (2004) 1.78
Lung cancer stem cells: tools and targets to fight lung cancer. Oncogene (2010) 1.61
Epithelial-mesenchymal transition in EGFR-TKI acquired resistant lung adenocarcinoma. Anticancer Res (2010) 1.56
Evidence for self-renewing lung cancer stem cells and their implications in tumor initiation, progression, and targeted therapy. Cancer Metastasis Rev (2010) 1.46
Tyrosine kinase inhibitors in cancer therapy. Clin Biochem (2004) 1.36
Side population analysis using a violet-excited cell-permeable DNA binding dye. Stem Cells (2006) 1.29
Activation of tyrosine kinases in cancer. Oncologist (2003) 1.16
Quantifying the sensitivities of EGF receptor (EGFR) tyrosine kinase inhibitors in drug resistant non-small cell lung cancer (NSCLC) cells using hydrogel-based peptide array. Biosens Bioelectron (2010) 0.84
Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res (2009) 7.09
Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc Natl Acad Sci U S A (2012) 4.85
Binding of chromatin-modifying activities to phosphorylated histone H2A at DNA damage sites. Mol Cell (2004) 4.17
Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions. Nat Protoc (2012) 3.22
Peptide chips for the quantitative evaluation of protein kinase activity. Nat Biotechnol (2002) 3.05
Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells: the matrix sandwich method. Circ Res (2012) 2.91
Role of Dot1-dependent histone H3 methylation in G1 and S phase DNA damage checkpoint functions of Rad9. Mol Cell Biol (2005) 2.48
Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells. Nat Biotechnol (2012) 2.33
Science education. Educating future scientists. Science (2003) 1.97
Synthesis enables identification of the cellular target of leucascandrolide A and neopeltolide. Nat Chem Biol (2008) 1.83
Histone H2AX phosphorylation as a predictor of radiosensitivity and target for radiotherapy. J Biol Chem (2003) 1.79
3-D microwell culture of human embryonic stem cells. Biomaterials (2006) 1.77
Retinoic acid and bone morphogenetic protein signaling synergize to efficiently direct epithelial differentiation of human embryonic stem cells. Stem Cells (2007) 1.71
Effects of substrate mechanics on contractility of cardiomyocytes generated from human pluripotent stem cells. Int J Cell Biol (2012) 1.63
NuA4 subunit Yng2 function in intra-S-phase DNA damage response. Mol Cell Biol (2002) 1.51
The microwell control of embryoid body size in order to regulate cardiac differentiation of human embryonic stem cells. Biomaterials (2009) 1.46
EAP1, a Candida albicans gene involved in binding human epithelial cells. Eukaryot Cell (2003) 1.40
A global assessment of stem cell engineering. Tissue Eng Part A (2014) 1.38
Inhibition of human embryonic stem cell differentiation by mechanical strain. J Cell Physiol (2006) 1.36
Yeast G1 DNA damage checkpoint regulation by H2A phosphorylation is independent of chromatin remodeling. Proc Natl Acad Sci U S A (2006) 1.32
Eap1p, an adhesin that mediates Candida albicans biofilm formation in vitro and in vivo. Eukaryot Cell (2007) 1.32
Sensing, signalling and integrating physical processes during Saccharomyces cerevisiae invasive and filamentous growth. Microbiology (2002) 1.32
CDK-dependent Hsp70 Phosphorylation controls G1 cyclin abundance and cell-cycle progression. Cell (2012) 1.29
Engineering the stem cell microenvironment. Biotechnol Prog (2007) 1.23
TGFbeta/Activin/Nodal pathway in inhibition of human embryonic stem cell differentiation by mechanical strain. Biophys J (2008) 1.22
Poly(ADP-ribose) polymerase inhibitor induces accelerated senescence in irradiated breast cancer cells and tumors. Cancer Res (2010) 1.22
Scalable culture and cryopreservation of human embryonic stem cells on microcarriers. Biotechnol Prog (2009) 1.21
Antifungal activity from 14-helical beta-peptides. J Am Chem Soc (2006) 1.21
Epigenetic modifications in double-strand break DNA damage signaling and repair. Clin Cancer Res (2010) 1.18
Innovation in the culture and derivation of pluripotent human stem cells. Curr Opin Biotechnol (2008) 1.18
Asynchronous cell cycle and asymmetric vacuolar inheritance in true hyphae of Candida albicans. Eukaryot Cell (2003) 1.18
Modulation of Wnt/β-catenin signaling in human embryonic stem cells using a 3-D microwell array. Biomaterials (2011) 1.16
Bcl-x(L) complements Saccharomyces cerevisiae genes that facilitate the switch from glycolytic to oxidative metabolism. J Biol Chem (2002) 1.16
Cryopreservation of adherent human embryonic stem cells. Biotechnol Bioeng (2004) 1.13
Directed differentiation of human embryonic stem cells to epidermal progenitors. Methods Mol Biol (2010) 1.12
Distinct domains of the Candida albicans adhesin Eap1p mediate cell-cell and cell-substrate interactions. Microbiology (2008) 1.12
Yeast cell death during DNA damage arrest is independent of caspase or reactive oxygen species. J Cell Biol (2004) 1.11
Identification of Candida albicans genes that induce Saccharomyces cerevisiae cell adhesion and morphogenesis. Biotechnol Prog (2005) 1.08
Short alkylated peptoid mimics of antimicrobial lipopeptides. Antimicrob Agents Chemother (2010) 1.08
Response of human prostate cancer cells and tumors to combining PARP inhibition with ionizing radiation. Mol Cancer Ther (2011) 1.08
Depression of Saccharomyces cerevisiae invasive growth on non-glucose carbon sources requires the Snf1 kinase. Mol Microbiol (2002) 1.07
Robust G1 checkpoint arrest in budding yeast: dependence on DNA damage signaling and repair. J Cell Sci (2002) 1.06
Analyzing the dose-dependence of the Saccharomyces cerevisiae global transcriptional response to methyl methanesulfonate and ionizing radiation. BMC Genomics (2006) 1.02
Marker-fusion PCR for one-step mutagenesis of essential genes in yeast. Yeast (2002) 1.01
CDK Pho85 targets CDK inhibitor Sic1 to relieve yeast G1 checkpoint arrest after DNA damage. Nat Struct Mol Biol (2006) 1.00
A pairwise chemical genetic screen identifies new inhibitors of glucose transport. Chem Biol (2011) 0.99
Peptide reporters of kinase activity in whole cell lysates. Biopolymers (2010) 0.98
Effect of sequence and structural properties on 14-helical beta-peptide activity against Candida albicans planktonic cells and biofilms. ACS Chem Biol (2009) 0.97
Relevance and irrelevance of DNA damage response to radiotherapy. DNA Repair (Amst) (2004) 0.97
Investigating quantitation of phosphorylation using MALDI-TOF mass spectrometry. J Mass Spectrom (2008) 0.97
Insulin inhibits cardiac mesoderm, not mesendoderm, formation during cardiac differentiation of human pluripotent stem cells and modulation of canonical Wnt signaling can rescue this inhibition. Stem Cells (2013) 0.97
A solid-phase Bcr-Abl kinase assay in 96-well hydrogel plates. Anal Biochem (2007) 0.96
Protein-acrylamide copolymer hydrogels for array-based detection of tyrosine kinase activity from cell lysates. Biomacromolecules (2005) 0.96
The response of human embryonic stem cell-derived endothelial cells to shear stress. Biotechnol Bioeng (2008) 0.95
Development of macroporous poly(ethylene glycol) hydrogel arrays within microfluidic channels. Biomacromolecules (2010) 0.93
Radiation-inducible immunotherapy for cancer: senescent tumor cells as a cancer vaccine. Mol Ther (2012) 0.92
The utilization of a Saccharomyces cerevisiae HUG1P-GFP promoter-reporter construct for the selective detection of DNA damage. Mutat Res (2007) 0.92
Human embryonic stem cell-derived keratinocytes exhibit an epidermal transcription program and undergo epithelial morphogenesis in engineered tissue constructs. Tissue Eng Part A (2010) 0.91
Development of Scalable Culture Systems for Human Embryonic Stem Cells. Biochem Eng J (2010) 0.91
A small molecule inhibitor of SRC family kinases promotes simple epithelial differentiation of human pluripotent stem cells. PLoS One (2013) 0.91
Hydrogel-based protein array for quantifying epidermal growth factor receptor activity in cell lysates. Anal Biochem (2009) 0.90
Use of protein-acrylamide copolymer hydrogels for measuring protein concentration and activity. Anal Biochem (2004) 0.89
Structure-activity relationships among antifungal nylon-3 polymers: identification of materials active against drug-resistant strains of Candida albicans. J Am Chem Soc (2014) 0.89
Polyelectrolyte multilayers fabricated from antifungal β-peptides: design of surfaces that exhibit antifungal activity against Candida albicans. Biomacromolecules (2010) 0.88
Generation and differentiation of human embryonic stem cell-derived keratinocyte precursors. Tissue Eng (2006) 0.88
Effect of pH, counter ion, and phosphate concentration on the glass transition temperature of freeze-dried sugar-phosphate mixtures. Pharm Res (2004) 0.88
Phase behavior of freeze-dried phospholipid-cholesterol mixtures stabilized with trehalose. Biochim Biophys Acta (2005) 0.87
Concise review: tissue-specific microvascular endothelial cells derived from human pluripotent stem cells. Stem Cells (2014) 0.87
A bead-based activity screen for small-molecule inhibitors of signal transduction in chronic myelogenous leukemia cells. Mol Cancer Ther (2010) 0.87
An essential function of yeast cyclin-dependent kinase Cdc28 maintains chromosome stability. J Biol Chem (2002) 0.87
Engineering the human pluripotent stem cell microenvironment to direct cell fate. Biotechnol Adv (2013) 0.87
Microwell regulation of pluripotent stem cell self-renewal and differentiation. Bionanoscience (2012) 0.86
Modeling the blood-brain barrier using stem cell sources. Fluids Barriers CNS (2013) 0.86
Assaying Bcr-Abl kinase activity and inhibition in whole cell extracts by phosphorylation of substrates immobilized on agarose beads. Anal Biochem (2005) 0.86
Saccharomyces cerevisiae JEN1 promoter activity is inversely related to concentration of repressing sugar. Appl Environ Microbiol (2004) 0.86
Photocleavable peptide hydrogel arrays for MALDI-TOF analysis of kinase activity. Analyst (2006) 0.86
Efficient generation of functional epithelial and epidermal cells from human pluripotent stem cells under defined conditions. Tissue Eng Part C Methods (2013) 0.86
Electroporation of human embryonic stem cells: Small and macromolecule loading and DNA transfection. Biotechnol Prog (2006) 0.85
Fabrication and selective functionalization of amine-reactive polymer multilayers on topographically patterned microwell cell culture arrays. Biomacromolecules (2011) 0.84
Quantifying the sensitivities of EGF receptor (EGFR) tyrosine kinase inhibitors in drug resistant non-small cell lung cancer (NSCLC) cells using hydrogel-based peptide array. Biosens Bioelectron (2010) 0.84
A magnetic bead-based protein kinase assay with dual detection techniques. Anal Biochem (2010) 0.84
Enzyme encapsulation in permeabilized Saccharomyces cerevisiae cells. Biotechnol Prog (2004) 0.84
Effects of 3D microwell culture on growth kinetics and metabolism of human embryonic stem cells. Biotechnol Appl Biochem (2012) 0.83
Quantification of kinase activity in cell lysates via photopatterned macroporous poly(ethylene glycol) hydrogel arrays in microfluidic channels. Biomed Microdevices (2012) 0.83
Dissection of Rad9 BRCT domain function in the mitotic checkpoint response to telomere uncapping. DNA Repair (Amst) (2009) 0.83
Disruption of LRG1 inhibits mother-daughter separation in Saccharomyces cerevisiae. Yeast (2005) 0.82
Hydrophobicity and helicity regulate the antifungal activity of 14-helical β-peptides. ACS Chem Biol (2014) 0.82
Cellular response to DNA damage. Ann N Y Acad Sci (2005) 0.82
Non-catalytic function for ATR in the checkpoint response. Cell Cycle (2007) 0.82
Control of the yeast cell cycle with a photocleavable alpha-factor analogue. Angew Chem Int Ed Engl (2006) 0.81
Optimizing thiophosphorylation in the presence of competing phosphorylation with MALDI-TOF-MS detection. J Proteome Res (2005) 0.81
Phosphoprotein profiling by PA-GeLC-MS/MS. J Proteome Res (2008) 0.81
Rapid validation of Mascot search results via stable isotope labeling, pair picking, and deconvolution of fragmentation patterns. Mol Cell Proteomics (2009) 0.81